Skip to content

Immix Biopharma, Inc. IMMX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Allogene Therapeutics logo
Allogene TherapeuticsALLO
$38.82M-11.9%
Regenxbio logo
RegenxbioRGNX
$45.54M-12.6%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$8.19M+42.1%
Xencor logo
XencorXNCR
$36.82M-2.2%
Immunome logo
ImmunomeIMNM
$2.83M-32.1%
Precigen logo
PrecigenPGEN
$4.37M-13.8%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s operating lease ROU assets?
Immix Biopharma, Inc. (IMMX) reported operating lease ROU assets of $927.73K in Q1 2026.
How has Immix Biopharma, Inc.'s operating lease ROU assets changed year-over-year?
Immix Biopharma, Inc.'s operating lease ROU assets decreased by 4.2% year-over-year, from $968.44K to $927.73K.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.